{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:08:40Z","timestamp":1777597720800,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00520-020-05855-6","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T20:02:31Z","timestamp":1604347351000},"page":"2811-2820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-2243","authenticated-orcid":false,"given":"Raiza","family":"Querrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3062-3247","authenticated-orcid":false,"given":"Nath\u00e1lia","family":"Ferrare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7268-485X","authenticated-orcid":false,"given":"Nilce","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4712-9779","authenticated-orcid":false,"given":"Cristine Miron","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-3366","authenticated-orcid":false,"given":"Paula Elaine Diniz","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-9345","authenticated-orcid":false,"given":"Carla Ruffeil Moreira","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-8782","authenticated-orcid":false,"given":"Gabriel Alvares","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7803-4740","authenticated-orcid":false,"given":"Andr\u00e9 Ferreira","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7285-7869","authenticated-orcid":false,"given":"Paulo Tadeu","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"5855_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (AREDIA) and zoledronate (ZOMETA) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131118","journal-title":"J Oral Maxillofac Surg"},{"key":"5855_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"42","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson DB, Fantasia J, Gooday R, Aghaloo T, Mehrotra B et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 Update. J Oral Maxillofac Surg 42:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"5855_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ctrv.2015.04.007","volume":"41","author":"IS Hamadeh","year":"2015","unstructured":"Hamadeh IS, Ngwa BA, Gong Y (2015) Drug induced osteonecrosis of the jaw. Cancer Treat Rev 41:455\u2013464","journal-title":"Cancer Treat Rev"},{"key":"5855_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.coms.2015.06.008","volume":"27","author":"SL Ruggiero","year":"2015","unstructured":"Ruggiero SL (2015) Diagnosis and staging of medication-related osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am 27:479\u2013487","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"5855_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"36","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 36:756\u2013765","journal-title":"N Engl J Med"},{"key":"5855_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","volume":"377","author":"K Fizazi","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M, Dami\u00e3o R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q, Tadros S, Dansey R, Goessl C (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet. 377:813\u2013822","journal-title":"Lancet."},{"key":"5855_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733\u2013759","journal-title":"Osteoporos Int"},{"key":"5855_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 48:677\u2013692","journal-title":"Bone."},{"key":"5855_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/2231-0762.178742","volume":"6","author":"D Rosella","year":"2016","unstructured":"Rosella D, Papi P, Giardino R (2016) Medication-related osteonecrosis of the jaw: clinical and practical guidelines. J Int Soc Prev Community Dent 6:97\u2013104","journal-title":"J Int Soc Prev Community Dent"},{"key":"5855_CR10","doi-asserted-by":"crossref","unstructured":"Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ (1997) Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosire 5\u201d\u2013(beta,gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12:1358-1367","DOI":"10.1359\/jbmr.1997.12.9.1358"},{"key":"5855_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jocd.2008.02.002","volume":"11","author":"PD Delmas","year":"2008","unstructured":"Delmas PD (2008) Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. J Clin Densitom 11:325\u2013338","journal-title":"J Clin Densitom"},{"key":"5855_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1517\/14740338.2010.516249","volume":"10","author":"I Charopoulos","year":"2011","unstructured":"Charopoulos I, Orme S, Giannoudis PV (2011) The role and efficacy of denosumab in the treatment of osteoporosis: an update. Expert Opin Drug Saf 10:205\u2013217","journal-title":"Expert Opin Drug Saf"},{"key":"5855_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cllc.2015.06.004","volume":"16","author":"J de Castro","year":"2015","unstructured":"de Castro J, Garc\u00eda R, Garrido P (2015) Therapeutic potential of denosumab in patients with lung cancer: beyond prevention of skeletal complications. Clin Lung Cancer 16:431\u2013446","journal-title":"Clin Lung Cancer"},{"key":"5855_CR14","first-page":"2275","volume":"12","author":"PJ Bekker","year":"2005","unstructured":"Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM (2005) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004. J Bone Miner Res 12:2275\u20132282","journal-title":"J Bone Miner Res"},{"key":"5855_CR15","volume-title":"Joanna Briggs Institute Reviewers\u2019 Manual: 2014 Edition","author":"Institute TJB","year":"2014","unstructured":"Institute TJB (2014) Joanna Briggs Institute Reviewers\u2019 Manual: 2014 Edition. Joanna Briggs Institute, Adelaide [Internet]. [cited Jul 18 2019]. Availablefrom: http:\/\/joannabriggs.org\/assets\/docs\/sumari\/ReviewersManual-2014.pdf"},{"issue":"7","key":"5855_CR16","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed1000097","journal-title":"PLoS Med"},{"key":"5855_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, PRISMA-P Group et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1\u20139","journal-title":"Syst Rev"},{"key":"5855_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00520-013-2022-1","volume":"22","author":"D Henry","year":"2014","unstructured":"Henry D, Vadhan-Raj S, Hirsh V, von Moos R, Hungria V, Costa L, Woll PJ, Scagliotti G, Smith G, Feng A, Jun S, Dansey R, Yeh H (2014) Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: a analysis of data from patients with solid tumors. Support Care Cancer 22:679\u2013687","journal-title":"Support Care Cancer"},{"key":"5855_CR19","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347","journal-title":"Ann Oncol"},{"key":"5855_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajoms.2015.03.005","volume":"27","author":"A Matsui","year":"2015","unstructured":"Matsui A, Kurihara J, Morishima H, Suzuki H, Sato S, Yamauchi K, Takahashi T (2015) Medication related osteonecrosis of the jaw (MRONJ): a retrospective survey of a series of patients treated according to the AAOMS guidelines. J Oral Maxillofac Surg Med Pathol 27:757\u2013763","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"5855_CR21","doi-asserted-by":"publisher","first-page":"20170323","DOI":"10.1259\/dmfr.20170323","volume":"47","author":"A Baba","year":"2018","unstructured":"Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M et al (2018) CT imaging features of antiresorptive agent-related osteonecrosis of the jaw\/medication-related osteonecrosis of the jaw. Dentomaxillofac Radiol 47:20170323","journal-title":"Dentomaxillofac Radiol"},{"key":"5855_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1259\/dmfr.20160065","volume":"45","author":"C Klingelhoffer","year":"2016","unstructured":"Klingelhoffer C, Klingelhoffer M, M\u00fcller S, Ettl T, Wahlmann U (2016) Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw? Dentomaxillofac Radiol. 45:1\u20137","journal-title":"Dentomaxillofac Radiol."},{"key":"5855_CR23","doi-asserted-by":"publisher","first-page":"20190132","DOI":"10.1259\/dmfr.20190132","volume":"48","author":"N Heim","year":"2019","unstructured":"Heim N, G\u00f6tz W, Kramer FJ, Faron A (2019) Antiresorptive drug-related changes of the mandibular bone densitiy in medication-related osteonecrosis of the jaw patients. Dentomaxillofac Radiol. 48:20190132","journal-title":"Dentomaxillofac Radiol."},{"key":"5855_CR24","first-page":"31496","volume":"19","author":"SEC Pichardo","year":"2019","unstructured":"Pichardo SEC, Broek FWT, Fiocco M, Appelman-Dijkstra NM, van Merkesteyn JPR (2019) A comparison of the cone beam computed tomography (CBCT) findings in medication-related osteonecrosis of the jaws (MRONJ) related to denosumab vs. bisphosphonates: an observational pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 19:31496\u201331498","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"5855_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcms.2012.10.014","volume":"41","author":"SE Pichardo","year":"2013","unstructured":"Pichardo SE, Kuypers SC, van Merkesteyn JP (2013) Denosumab osteonecrosis of the mandible: a new entity? A case report. J Cranio-Maxillofac Surg 41:65\u201369","journal-title":"J Cranio-Maxillofac Surg"},{"key":"5855_CR26","first-page":"326","volume":"3","author":"A Limones","year":"2020","unstructured":"Limones A, S\u00e1ez-Alcaide LM, D\u00edaz-Parre\u00f1o SA, Helm A, Bornstein MM, Molinero-Mourelle P (2020) Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab vs. zoledronic acid: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 3:326\u2013336","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"5855_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tripleo.2007.01.040","volume":"104","author":"SD Bianchi","year":"2007","unstructured":"Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M (2007) Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:249\u2013258","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5855_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.tripleo.2009.12.005","volume":"109","author":"NS Treister","year":"2010","unstructured":"Treister NS, Friedland B, Woo SB (2010) Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:753\u2013764","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5855_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.joms.2008.12.002","volume":"67","author":"K Arce","year":"2009","unstructured":"Arce K, Assael LA, Weissman JL, Markiewicz MR (2009) Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 67:75\u201384","journal-title":"J Oral Maxillofac Surg"},{"key":"5855_CR30","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","volume":"28","author":"AT Stopeck","year":"2010","unstructured":"Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, Boer RH et al (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28:5132\u20135139","journal-title":"J Clin Oncol"},{"key":"5855_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","volume":"19","author":"N Raje","year":"2018","unstructured":"Raje N, Terpos E, Willenbacher W, Shimizu K, Garc\u00eda-Sanz R, Durie B, Legie\u0107 W, Krej\u010d\u00ed M, Laribi K, Zhu L, Cheng P, Warner D, Roodman GD (2018) Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol 19:370\u2013381","journal-title":"Lancet Oncol"},{"key":"5855_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","volume":"7","author":"GV Scagliotti","year":"2012","unstructured":"Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, Garc\u00eda-S\u00e1enz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A, Jacobs I (2012) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7:1823\u20131829","journal-title":"J Thorac Oncol"},{"key":"5855_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.14219\/jada.archive.2012.0323","volume":"143","author":"P Diz","year":"2012","unstructured":"Diz P, Lopez-Cedrun JL, Arenaz J, Scully C (2012) Denosumab-related osteonecrosis of the jaw. J Am Dent Assoc 143:981\u2013984","journal-title":"J Am Dent Assoc"},{"key":"5855_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcms.2017.11.008","volume":"46","author":"VLDN Poubel","year":"2018","unstructured":"Poubel VLDN, Silva CAB, Mezzomo LAM, De Luca Canto G, Rivero ERC (2018) The risk of osteonecrosis on alveolar healing after tooth extraction and systemic administration of antiresorptive drugs in rodents: a systematic review. J Craniomaxillofac Surg 46:245\u2013256","journal-title":"J Craniomaxillofac Surg"}],"updated-by":[{"DOI":"10.1007\/s00520-021-06129-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000}}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05855-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T22:10:23Z","timestamp":1627683023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05855-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5855"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05855-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00520-021-06129-5","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00520-021-06129-5","URL":"https:\/\/doi.org\/10.1007\/s00520-021-06129-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}